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Abstract 
The prevalence of cardiovascular disease (CVD) is increasing
around the globe and is the leading cause of death around the world.
Though once thought of as an adult problem, it is now recognised
that the early manifestations of disease may occur during childhood.
Numerous risk factors have been linked to CVD with much of the
research focusing on understanding the prevalence and relationship
of traditional risk factors such as dyslipidemia, smoking, diabetes
mellitus, hypertension, obesity, psychosocial stress, poor diet, phys-
ical inactivity and alcohol consumption to the early etiology of dis-
ease. While this line of investigation has greatly enhanced our
understanding of the relationship between these risk factors and
disease, they do not fully explain all cardiovascular events. To
enhance our understanding and help with the management of CVD,
investigations that involve the measurement of traditional as well as
novel risk factors may be necessary. Public health strategies that
aim to reduce the prevalence of obesity and overweight encourage
youth to increase their physical activity levels as a means of protect-
ing against poor cardiometabolic profiles. Interventions that
increase physical activity levels and improve cardiorespiratory fit-
ness cause a reduction in certain CVD risk factors but the lack of
agreement between findings makes it impossible to give precise
recommendations that will ensure CVD risk reduction. Yet it is
important that research continues in order to establish the most
appropriate means of improving the health and well-being of those
at most risk of future CVD. 
Introduction
Cardiovascular disease (CVD) has been the leading cause of
death in developed countries since the early 1900s.1 While the risk
of cardiovascular mortality was once relatively low in youth, accu-
mulating evidence suggests that CVD has its origins in childhood.2,3
Numerous risk factors have been linked to the development of CVD
and include; poor dietary habits, overweight and obesity, hyperten-
sion, insulin resistance or diabetes mellitus, alcohol consumption,
smoking, poor physical activity levels and dyslipidemia.4 Of rele-
vance, many of these risk factors are related and reversible through
a healthy diet and increased physical activity. Given that childhood
obesity increases the risk of becoming obese in adulthood, and that
obesity at any age is associated with numerous co-morbidities such
as, type 2 diabetes, CVD risk, hypertension, asthma, depression, cer-
tain cancers, and sleep apnoea,1 reversing current trends in obesity
prevalence seems vital.
More than 100 emerging risk factors have been suggested as
potential markers for improving CVD risk classification. Several of
these novel biomarkers have generated significant interest within
the scientific community since they may provide additional means
of improving CVD risk assessment. Some of these more widely
investigated biomarkers include C-reactive protein (CRP),
adiponectin, homocysteine, plasminogen activator inhibitor-1 (PAI-
1), interleukin-6 (IL-6) and fibrinogen (Fg). Much of the evidence
linking these markers to CVD nonetheless has been derived from
adult populations. Despite the extremely low risk of early mortality
in youth, early and continued exposure to an unhealthy CVD profile
may accentuate the risk of early mortality. 
In order for public health strategies to be effective within youth
populations, it may be necessary to evaluate both traditional and
novel CVD risk factors to determine the most effective means of
reducing unhealthy metabolic profiles. Thus, this review will pro-
vide an overview of the current literature concerning six of the
widely investigated novel metabolic CVD risk factors while examin-
ing their associations with physical activity, obesity and measures of
physical fitness.Adiponectin
Adiponectin is an adipose specific hormone produced and secret-
ed by adipose tissue which circulates in the blood in three forms
(low, medium, and high), with the high-molecular-weight form
appearing to be more pathogenic.5 Unlike other adipocytiknes (cell
signalling proteins released by adipokines) such as interleukin-6
(IL-6) and plasminogen activator inhibitor-1 (PAI-1), adiponectin
levels are lower in obese and overweight individuals.6 In adults, low
Significance for public health
As the prevalence of traditional CVD risk factors seem to becoming more evi-
dent in childhood, it is vital that pre-emptive interventions are implemented
early in one’s life before the associated cardiovascular complications are
established. Childhood is seen as an ideal phase for intervention. This is the
stage in one’s life where behaviors are established which, if left unabated,
may continue into adulthood. Yet, this is also a stage where behaviors can be
influenced. Improved understanding of the effects of different physical activ-
ity interventions upon CVD risk factors may provide new avenues for inter-
vention that can provide the best means of protection against current and
future cardiovascular complications for all youth. Since the role of Physical
Education is, to some extent, continually marginalized within the curricu-
lum, it is important that policy makers realise the importance of this setting
and its role in the health of school age youth. Thus, further work is neces-
sary within this setting to disentangle the causal relationships between
physical activity, physical fitness and CVD risk. 
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levels of adiponectin have been known to predict outcomes such as
CVD and type 2 diabetes7 and if found in childhood, may exacerbate
the prevalence of these disorders when adulthood is reached. Obese
children as young as 6-9 yrs have been known to have decreased
adiponectin levels, in comparison to non obese children, with nega-
tive associations apparent for measures of  BMI and IR ( both fasting
insulin levels and HOMA).6 Puberty seems to have an effect on
adiponectin levels with some studies demonstrating significant dif-
ferences in adiponectin levels between and within genders during
adolescence.8
Data from the Québec Child and Adolescent Health and Social
Survey which involved 1632 French Canadian youth aged 9, 13, and
16 yr demonstrated that for all age groups, boys displayed signifi-
cantly lower concentrations of adiponectin in comparison to girls.8
Further analysis found that mean adiponectin levels were signifi-
cantly lower at age 16 compared to 9 yrs for boys (27.7%, P<0.0001)
and for girls (13.3%, P<0.0001) with changes in BMI the attributed
cause. Similar findings were also seen in European children and
adolescents with adiponectin levels being lower in lean male adoles-
cents than girls of the same age.9 Interestingly the authors also
measured testosterone levels and found that the significant differ-
ence noted between boys was inversely related to testosterone (r=-
0.42; P<0.0001) levels. It seems that differing testosterone levels
apparent between genders during adolescence may explain apparent
gender differences during this period.
Improving weight status seems important for healthy adiponectin
levels in youth. Whether increasing physical activity levels and
improving measures of physical fitness has the same beneficial
effects are unclear. Though some have observed a positive effect of
increased physical activity on adiponectin levels,10,11 others have
not.12 In the study by Kim and colleagues,11 obese adolescents were
involved in a 6-week jump rope intervention. While the participants
experienced significant improvements in adiponectin levels post-
intervention, significant improvements in body fat % (%BF) were
experienced also. Similarly reductions in %BF were also noted in the
participants who experienced significant increases in adiponectin in
the study by Balagapol and colleagues10 and seem to imply that a
reduction in %BF may be necessary for the effects of exercise upon
adiponectin levels to become apparent in adolescents. Interleukin-6 
IL-6 is considered a pro-inflammatory and immunoregulating
cytokine produced from adipose tissue.13 Resting levels of IL-6 are
known to be elevated in obese adults and are positively related to adi-
posity, particularly central body fat, while correlating with IR.14
Unsurprisingly, IL-6 has been proposed as playing a key role in the
relationship between adiposity, inflammation, and CVD. Though one
would expect elevated levels of IL-6 to be present in obese youth,
findings have been somewhat contradictory. In a recent study involv-
ing European obese and overweight children (10 yrs), being over-
weight or obese was significantly associated with elevated levels of
IL-6, the extent of which was exacerbated with increasing weight
status.15 Similar findings were also seen in older participants (15-16
yrs) with obese adolescents demonstrating positive associations
between IL-6 and measures of adiposity (body weight, BMI, and body
fat mass) and IR (HOMA).16 Interestingly within this study, the
obese participants also demonstrated similar positive associations
with other pro-inflammatory biomarkers (C-reactive protein and fib-
rinogen).
Similarly, significant differences in the levels of IL-6 were seen in
severely obese children and adolescents from Austria (12±4 yrs)
when compared to their lean counterparts. Collectively, these studies
seem to indicate the presence of an inflammatory state early in the
clinical course of obesity.17 Nevertheless, others studies have not
confirmed these assertions.13,18,19 In the study by Caballero et al. sig-
nificant differences between obese and lean participants (10-18 yrs),
of Hispanic (Latino) origin, were seen in concentrations of C-reac-
tive protein, PAI-1 and adiponectin though no differences were noted
for IL-6. Comparable findings were also seen in younger, pre-puber-
tal children.19 Here the authors demonstrated significant differences
in C-reactive protein, insulin, PAI-1 levels and IR (HOMA) between
obese and non-obese individuals though no differences were noted
in IL-6 levels. In a recent study some have even suggested that IL-6
levels may be influenced by age and gender.13 In this longitudinal
study conducted over 7 years, IL-6 levels were measured at 8 and 15
yrs in both healthy and overweight children. Though no significant
differences were noted between the two groups at the first measure-
ment, the authors did note that significant differences existed with
regards to IR (HOMA). During adolescence significant differences
were noted in females with the overweight participants having sig-
nificantly higher IL-6 levels than their normal weight counterparts.
Interestingly, no significant differences were noted between the boys
at either measurement.18,19
Based on the contradictory findings of these studies it is difficult
to establish the associations between IL-6 and adiposity in youth
populations. Though it is acknowledged that obese adults seem to
present with elevated IL-6 levels in comparison to their leaner coun-
terparts, making such an assertion in youth populations is difficult
at this stage. Limited studies have focused on the associations
between adiposity and IL-6 in healthy and overweight youth popula-
tions and until such case, further work is needed to establish this
relationship. Nevertheless, as IL-6 is produced and secreted from
adipose tissue it is sensible to expect that IL-6 levels should be
raised in obese children and adolescents. It may be that the expres-
sion of elevated IL-6 levels in plasma is proceeded by other factors
involved in the disease process as found by Tam and colleagues who
noted the prevalence of IR in obese youth at 8 yrs despite compara-
ble levels of IL-6 in lean individuals with no prevalence of IR.13
Though studies reporting on the effects of physical activity and
physical fitness on IL-6 levels in youth are sparse, some evidence
does exists that supports the protective effects of both. In a group of
640 pre-adolescents (49% boys), Platat and others demonstrated that
subjective measures of physical activity was independently and neg-
atively associated with IL-6 after adjustment for sex, sexual maturi-
ty and socio-economic status.20 Though beneficial relationships were
also noted between physical activity and C-reactive protein,
adiponectin and leptin, it was interesting to note that only IR
(HOMA) and IL-6 were the only significant associations after con-
trolling for adiposity (body fat mass) and fat localization (waist-hip-
ratio). However in two recent studies, objectively measured physical
activity and cardiorespiratory fitness was not shown to be associated
with IL-6 levels in either 13-17 yrs individuals21 or in 9 yr olds.22 This
was found despite measures of adiposity and low cardiorespiratory
fitness being shown to predict the clustering of CVD risk (composite
score produced from measures of systolic BP, triglyceride, IR
(HOMA), and cholesterol to HDL ratio)22 and elevated C-reactive pro-
tein levels and IR (HOMA).21 Though Andersen and colleagues sug-
gest that the reason for the lack of association noted in their study
between IL-6 and CVD risk may relate to the young age of partici-
pants whereby not enough time may have lapsed for this association
to develop, this was not supported in the study by Martinez-Gomes
and colleagues. Clearly, more longitudinal research seems warranted
to determine the associations and effects of IL-6 levels upon indices
of CVD risk during youth and subsequent adulthood.
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Homocysteine
Homocysteine is a sulphur-containing amino acid derived from
methionine, with elevated levels known to be linked to endothelial
damage, platelet activation and altered thrombus formation.23 At
present there is no international consensus regarding a cut-off point
for hyperhomocysteinaemia in youth populations though the
American Heart Association have proposed a normal range for fast-
ing homocysteine of between 5-15 μmol/L in adults.24 Though there
is a dearth of evidence relating to youth compared to adults, the
available evidence does appear to concur with these ranges.25-27 In a
study by Kerr and colleagues,26 the authors used data from the
National Dietary and Nutritional Survey of 2127 youths aged
between 4 to 18 years to produce age-specific reference values for
homocysteine. From their findings, homocysteine concentrations
were found to progressively increase with age with median values of
5.6, 6.3, and 7.9 μmol/L noted in youth aged 4 to 10 years, 11 to14
years, and 15 to 18 years, respectively. Ranges for total homocysteine
have also been presented by Reddy27 for apparently healthy youth
aged between 9 and 14 years of 8.3±3.7 μmol/L in boys and 8.3±3.3
μmol/L in girls though the differences in ages between the two
cohorts make comparison difficult. It does appear nonetheless that
specific gender differences do exist in youth with boys typically pre-
senting with significantly higher levels of homocysteine than
girls.26,28,29
The age at which specific gender differences in homocysteine lev-
els become apparent is unclear. Some have noted specific gender dif-
ferences from the age of 15 years,26,29 while others have reported sig-
nificant gender differences in homocysteine levels at a younger
age.25,28 One possible explanation for the apparent discrepancies
between studies may relate to the levels of gender specific hormones
evident from the onset of puberty.  For instance, the rise in oestro-
gen levels in females at the onset of puberty is known to be protec-
tive against the rise in homocysteine levels,30 whereas the rise in
testosterone levels in males has been postulated as a possible expla-
nation for their elevated  homocysteine levels.31 Whether these
apparent gender differences pose a significant risk to future health
is unclear given that the role of homocysteine has yet to be conclu-
sively confirmed as a risk factor for future CVD.26 Nonetheless,
hyperhomocysteinaemia, which can be defined as an elevated con-
centration of fasting plasma total homocysteine, has been associat-
ed with an increase in the possibility of suffering from CVD related
disorders later in life.25,32 Importantly though, homocysteine levels
are known to be modifiable.
Lifestyle factors such as poor physical activity levels, smoking sta-
tus, excessive alcohol consumption and obesity have all been associ-
ated with elevated levels of homocysteine in adults.33,34 Previous
investigations have also demonstrated that homocysteine concentra-
tions are associated with indices of childhood obesity,35,36 but
whether the associations between homocysteine concentrations and
physical activity and cardiorespiratory fitness as in adults, is unclear.
To date, limited studies are available that have examined the possi-
ble associations between physical activity, physical fitness and
homocysteine levels in youth. However, in a study involving 156
Spanish adolescents (76 boys and 80 girls), Ruiz and colleagues did
examine the associations between .cardiorespiratory fitness as seen
in adults is evident in youth, is unclear. From their findings, the
authors rather interestingly noted a significant inverse association
between homocysteine and cardiorespiratory fitness in girls though
no associations were apparent in boys.37 These findings have also
been noted in a previous investigation involving adults,38 and seem
to suggest that sex specific hormones may play a role in mediating
the homocysteine-cardiorespiratory fitness relationship.37
To the best of our knowledge, no studies have examined the inde-
pendent effects of a physical activity intervention upon homocys-
teine levels in youth. Gallistl and colleagues36 did however demon-
strate a positive effect on the homocysteine levels in obese children
(aged 10-14 years) after only 3 weeks of a combined physical activi-
ty and dietary intervention. Nonetheless, the lack of information pro-
vided concerning the physical activity performed means that it is dif-
ficult to elucidate the effects of the activity upon homocysteine lev-
els, particularly when measures of adiposity significantly decreased
post-intervention also. It is clear that further investigations are
required to determine the extent increasing physical activity and or
cardiorespiratory fitness has upon homocysteine levels in youth.
Furthermore, longitudinal tracking studies are also required to con-
firm whether a relationship between youth and adult levels of homo-
cysteine is apparent and indeed whether these levels in youth have
any impact upon CVD risk in adulthood. Plasminogen activator inhibitor-1
PAI-1 is a globular glycoprotein with a molecular weight of 50,000;
it is comprised of 379 amino acids in a single chain whose structure
designates it as a member of the superfamily of serine protease
inhibitors (serpins).23 Previous investigations have established that
higher circulating PAI-1 levels are associated with increased risk of
CVD and are associated with with obesity, hyperinsulinemia and
type 2 diabetes.24 The synthesis and production of PAI-1 mainly
occurs through endothelial cells though other types of tissue pro-
duce PAI-1 such as hepatocytes and adipocytes. The underlying
mechanism that results in elevated PAI-1 levels is a complex process
and at present is not fully understood. A detailed discussion of this
is out with the scope of this paper and the reader is directed towards
two detailed review articles for a more comprehensive discussion on
this matter.25,26 Of particular interest though is the link between
elevated PAI-1 levels and obesity. Raised PAI-1 levels in adults con-
sistently appear in obese individuals and are known to increase the
susceptibility of atherothrombotic events in such individuals. In
blood, fibrinolysis breaks down fibrin or blood clots and is essential
to prevent adverse thrombus formation. PAI-1 is known to be a
potent inhibitor of fibrinolysis with elevated levels consistently
found in obese individuals and is known to predict the occurrence of
myocardial infarction.24 The metabolic syndrome is a cluster of
metabolic abnormalities that can co-occur in an individual. Such
abnormalities include obesity (visceral), hyperinsulinemia, dyslipi-
demia, elevated triglyceride levels, impaired glucose tolerance,
hypertension and low HDL-C levels which are all well established risk
factors for CVD.27 Evidence now suggests that elevated PAI-1 levels
are linked to the metabolic syndrome as well as type 2 diabetes.25
However, PAI-1 is not associated with all components of the metabol-
ic syndrome. Though studies have demonstrated a positive associa-
tion between PAI-1 levels and measures of adiposity (BMI and WC),
IR and hyperglycemia,28 it is not associated with dyslipidemia.25
Previous studies have also demonstrated a threefold increase in PAI-
1 levels in obese diabetic subjects when compared to lean counter-
parts29 and predictably, measures of adiposity, and in particular cen-
tral adiposity, are seen as one of the main factors associated with
impaired fibrinolysis and elevated PAI-1 levels. 
Given the associations between the metabolic syndrome and ele-
vated levels of PAI-1 it is prudent to recommend a treatment of
lifestyle modifications in order to address both. Thus, the corner-
stone of such an approach lies in modifying dietary habits and
increasing physical activity levels. Previous investigations in adults
have shown that dietary interventions can lead to significant reduc-
tions in PAI-1 levels. In the study by Mavri and others the authors
demonstrated that after only a 3-month weight reduction programme
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consisting of a hypocaloric diet, obese adults experienced significant
reductions (-74%) in PAI-1 levels. Interestingly, the changes in PAI-
1 activity was also associated with reductions in insulin levels and
measures of adiposity (BMI and %BF).30 
In a similar study of induced energy intake restriction lasting for
11 weeks, significant improvements in PAI-1 levels (-50%) were seen
in obese elderly women after reductions in body weight and fat
mass.31 Studies investigating the effects of increased physical activ-
ity on PAI-1 levels however are scarce. Though previous investiga-
tions have demonstrated substantial improvements in PAI-1 levels
with increased physical activity, both of these studies have also
involved a dietary modification programme too.32,33 The independent
effects of increased physical activity on PAI-1 levels are thus impos-
sible to elucidate. Nevertheless, it is interesting to note that in both
of these studies, reductions in PAI-1 levels were accompanied by sig-
nificant weight loss and a reduction in plasma insulin levels though
this did not reach significance in the latter study. 
In one of the few investigations that has looked at the independ-
ent effects of increased physical activity upon PAI-1 in adults aged
between 50 and 70 yrs, the authors demonstrated no decrease in lev-
els after 10 consecutive days of moderate intensity exercise train-
ing.34 Further, the authors also observed no significant reductions in
body weight after the intervention period. Closer inspection of the
results revealed that those individuals with higher body fatness did
however experience significant reductions in insulin levels post
intervention, unlike their leaner counterparts. Though speculative, it
appears that the maintenance of body weight during the intervention
period may explain the lack of positive effect upon PAI-1 activity.
Within youth populations, evidence also supports the benefits of
behaviour lifestyle modifications upon PAI-1 levels. In a study involv-
ing 60 obese pre-adolescents,35 significant reductions in elevated
PAI-1 levels were seen after only 3 weeks of a programme, which con-
sisted of a low-caloric diet and increased physical activity. Once more
reductions in PAI-1 levels were associated with a reduction in meas-
ures of BMI whereas those not experiencing a decrease in adiposity
saw no decrease in PAI-1 activity.
In a more recent study, the effects of a 6-month lifestyle interven-
tion upon on a number of CVD risk factors, including PAI-1 levels, in
eighty five obese adolescents from Mexico was examined.36 Analysis
of baseline results between the obese (n=86) and lean (n=36)
groups revealed significant differences in triglycerides, glucose,
insulin, PAI-1 and fibrinogen levels as one would expect. Post inter-
vention, the obese adolescents who experienced significant reduc-
tions in BMI also experienced significant reductions in fasting
insulin and PAI-1 levels. While this is an exciting finding, the nature
of the study and of those previously discussed highlights the limita-
tions of our understanding of the effects of lifestyle behaviours upon
PAI-1 levels.
For instance in the study by Huang and colleagues there was no
measures taken on participants to ensure whether they complied
with the dietary and physical activity recommendations. The authors
recommended that participants perform brisk walking for 30 min
daily during the first 2 weeks with the duration of activity increasing
to 1 h in the 3rd week and thereafter until the completion of the inter-
vention. Participants were also encouraged to undertake a variety of
activities such as cycling, jogging and swimming in addition to the
prescribed walking requirements. However it does not seem that this
was recorded by the participants or indeed by the authors. So
whether the effects of improved dietary habits and/or increased
physical activity resulted in the improvements noted is unclear. The
same concerns can be raised at the previous investigations men-
tioned within this section. As improvements in weight status and
adiposity are associated with improvements in fasting glucose and
insulin levels, it may be that the changes evident in these metabolic
indices are responsible for the improvements noted in fibrinolytic
activity. Given the dearth of studies available involving youth partic-
ipants, it is unclear whether the relationship between a reduction in
measures of adiposity and decreased PAI-1 levels is causal or indi-
rect. Further studies seems warranted to understand the independ-
ent effects of improvements in measures of adiposity and increased
physical activity upon PAI-1 levels before recommendations can be
made. Another important limitation of this topic is the use of obese
children and adolescents. While one can argue that these individuals
are in most need of intervention, the limited data available concern-
ing PAI-1 activity in youth limits the generalizability of findings to
non-obese populations. Further work needs to consider whether
improvements in PAI-1 levels are needed in non-obese cohorts and
whether improvements are noted in the absence of a reduction in
measures of adiposity.Fibrinogen
Fibrinogen is a soluble glycoprotein found in plasma, which is pre-
dominantly synthesised in the liver. Fibrinogen is the precursor of
fibrin and is an essential component of the blood coagulation system
and is known to play a vital role in a number of pathophysiological
processes within the body including inflammation, atherogenesis
and thrombogenesis.37 Several studies have reported that plasma fib-
rinogen levels are an independent risk factor for CVD,38,39 though the
exact mechanism whereby elevated fibrinogen levels leads to
atherothrombosis is unclear. 
Though fibrinogen is the precursor of fibrin, it is also an acute
phase protein whose release from the liver is mediated in response
to cytokines released in response to inflammation, infection and/or
tissue damage. For instance, it is known that increased IL-6 produc-
tion leads to an increase in fibrinogen synthesis whereas increased
levels of circulating PAI-1 can lead to hypofibrinolysis, a state in
which fibrinolysis is inhibited.5 Thus in addition to its vital role in
the final phase of the blood coagulation cascade, fibrinogen is also
known to promote platelet aggregation, smooth muscle cell migra-
tion and proliferation while also regulating whole blood and plasma
viscosity.5
No specific cut-off values are available for youth populations
though in adults, normal fibrinogen values range are said to range
from 150 to 350 mg/dL.40 It should be noted though that fibrinogen
levels are influenced by numerous factors such as age, gender, socio-
economic status, alcohol consumption, physical activity behaviour,
cardiorespiratory fitness and measures of adiposity,37 which need to
be considered when identifying at risk individuals. Previous investi-
gations in youth populations have revealed that elevated fibrinogen
concentrations are independently associated with measures of adi-
posity, cardiorespiratory fitness and physical activity. For instance,
findings from the Bogalusa Heart study have shown the ponderal
index (weight/ height3) and HDL-C to be independently associated
with fibrinogen in a cohort of 3047 children and adolescents of
mixed race and gender.41 Though fibrinogen levels measured in this
cohort (5 to 17 yrs) revealed no significant race and sex differences,
it was interesting to note that levels did increase significantly with
age and sexual maturation in African-American females. 
Similarly, in a smaller cohort of obese children (n=41) Ferguson
and colleagues noted significant differences in fibrinogen levels
between gender and race.42 Here boys were seen to have significant-
ly higher fibrinogen levels than girls whereas African-Americans had
significantly greater levels than Caucasians. Further analysis
revealed that gender and %BF explained significant amounts of the
variance in fibrinogen levels which led the authors to conclude the
debilitating role adiposity plays in youth blood haemostasis. 
Measures of adiposity (BMI, WC, WHR and %BF) have all been
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shown to be positively associated with levels of fibrinogen in adult
populations regardless of gender.37,43
The similar findings in youth populations seem to confirm adipos-
ity as a key contributor to elevated fibrinogen levels and implicate
the significance of modifying lifestyles as a key area for interven-
tion. Though one would expect a positive association upon fibrino-
gen levels with increased physical activity and cardiorespiratory fit-
ness in youth, cross-sectional evidence has revealed contradictory
findings in youth populations.44-48
For instance, the positive associations seen between subjective
measures of physical activity and fibrinogen in children and adoles-
cents of differing gender and ethnicity have to be viewed with cau-
tion as both failed to consider the potential effects of co-founders in
their analysis.45,47 When objective measures of physical activity were
captured in children however, no association was seen between
physical activity and fibrinogen levels after controlling for potential
co-founders (sex, age and pubertal development).44 Similarly with
regards to cardiorespiratory fitness, the independent associations
noted with physical activity in a range of individuals aged between 4
and 25 yrs46 was not confirmed in other studies involving obese ado-
lescent boys and girls48 or in pre-pubertal boys and girls.44
Differences in methodologies and sample participants may explain
the conflicting findings from these studies but further work is need-
ed to substantiate whether an association exists between physical
activity and measures of physical fitness and fibrinogen concentra-
tions in youth populations. C-reactive protein
CRP is a circulating acute-phase reactant whose production
increases significantly in response to trauma or inflammation.
Synthesized primarily in the liver, its release is principally stimulat-
ed by IL-6 and TNF-α production which reveals a direct link between
adipocytes and CRP.5 It is well established that inflammation is cen-
tral to CVD risk with elevated levels of inflammatory cytokines known
to be associated with atherosclerosis, with CRP being one of the
most sensitive indicators.49 Some have suggested that traditional
CVD risk factors only explain around 50% of cardiovascular morbidi-
ty and mortality,50 thus, the importance and utility of further predic-
tors such as CRP being used as an additional means of detecting
unfavourable lifestyle behaviours is now accepted. 
Inflammation resulting from injury, infection or irritation can be
deemed as either acute or chronic. Acute inflammation refers to the
body’s initial response to harmful stimuli caused either through
infection of trauma whereas chronic inflammation caused through
obesity, arthritis and atherosclerosis may last days or several years
resulting in the influx of inflammatory cells at the localized tissue.49
In both adults and youth populations, chronic inflammation is a com-
mon characteristic of being overweight and obese. Adipose tissue is
known to release a number of inflammatory biomarkers into the
blood stream, notably IL-6, which in turn can stimulate the release of
CRP from the liver into the blood stream.5 Given the association
between inflammation and the pathogenesis of disease, the study of
CRP as a predictor of future CVD events has received much attention
in recent years.
However, much of our understanding of CRP and its role in the
progression of atherosclerosis has come from the study of adults.
Nonetheless, the association between obesity and CRP levels is now
firmly established in both children and adolescents. In a cross sec-
tional study involving 699 British children (10-11 yrs), Cook and col-
leagues51 were the first to demonstrate the association between obe-
sity and inflammatory biomarkers. Findings revealed that CRP levels
were 47% higher in girls than in boys and when compared by age
groups, levels were seen to rise by 15%. Importantly though, CRP lev-
els were seen to be 270% higher in individuals who were in the top
quintile rather than the bottom quintile of the Ponderal index.
Though CRP was seen to be associated with several CVD risk factors
measured in this cohort, only the associations for fibrinogen, HDL-C
and systolic blood pressure held true after adjustment for adiposity.
Interestingly, further analysis revealed that adiposity was signifi-
cantly associated with all CVD risk factors measured (fasting glu-
cose, fibrinogen, triglyceride, total cholesterol, HDL-C, LDL-C and
insulin levels as well as systolic and diastolic blood pressure), even
after adjustment for age, gender, socio-economic status, and CRP
levels. These findings seem to imply that adiposity may affect CVD
risk factors through other pathways than those for CRP. 
Similar findings have also been reported in older cohorts (8-16
yrs) with overweight boys and girls presenting with CRP levels of
3.74 and 3.17 times greater than their normal weight counterparts.52
Longitudinal prospective studies have also demonstrated that CRP
levels track significantly from childhood into adulthood i.e. ages 3-18
to ages 24-39 yrs53 and from 16-25 yrs with Morrison and colleagues
noting unhealthy changes to BMI, WC and total cholesterol as being
the major determinants of CRP levels in adulthood.54 Though find-
ings from the Young Finns study revealed that childhood CRP levels
was not associated with adult carotid artery intimal medial thickness
(cIMT),53 others have found significant associations between CRP
levels and measures of atherosclerosis [cIMT and Brachial artery
flow-mediated dilatation (FMD)] in healthy children (10.5±1.1
yrs).55
Collectively, these findings support the predictive validity of CRP
measurement in identifying those at risk of current and/or future
CVD. With the established association between CRP and measures of
adiposity it not surprising that some have suggested that increasing
physical activity and cardiorespiratory fitness levels may prove use-
ful in reducing CRP levels in youth populations. However, current
evidence is scant and rather contradictory with regards to their
mediating role upon youth CRP levels.
Though some have shown significant associations between physi-
cal activity and CRP levels47,51 others have not.44 Nevertheless, the
evidence should be viewed with caution given the limitations of sub-
jective self-report measures and the failure to consider potential co-
founders such as measures of adiposity in some of these studies.
When physical activity has been measured using objective methods
(accelerometers) though, no associations were apparent with CRP in
a cohort of Swedish pre-pubertal children.44 The authors did howev-
er find a negative association between CRP and cardiorespiratory fit-
ness and a positive association with body fat, which suggests that
physical activity may have a protective role on low-grade inflamma-
tion through reductions in body fat and enhancement of cardiorespi-
ratory fitness. Similar contradictory evidence is apparent when
examining the associations between cardiorespiratory fitness and
CRP levels in youth. 
Though authors have demonstrated significant inverse associa-
tions between cardiorespiratory fitness and CRP levels in both pre-
pubertal and adolescents boys and girls22,56 others have not.57,58 One
possible explanation for the contradictory results may relate to the
methods used to measure cardiorespiratory fitness. In the former
studies cardiorespiratory fitness was measured on a treadmill
through continuous and progressive protocols whereas in the latter
studies the 20-m multistage fitness test (20-m MSFT) was used as an
estimate. Though laboratory measures may have produced a more
accurate measurement, the 20-m MSFT is accepted as a valid and
reliable test of cardiorespiratory fitness in young people and since
students are familiar with the test protocol, it is presumed that the
levels achieved are reliable estimates.
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Conclusions
CVD continues to be the leading cause of death in the Western
world. As the prevalence of CVD risk factors seem to becoming more
evident in childhood, it is vital that pre-emptive interventions are
implemented early in one’s life before associated cardiovascular
complications are established. As physical activity can influence obe-
sity directly, and given the associations between obesity and CVD
risk, it is important that we endeavor to disentangle this causal rela-
tionship. Individuals that are physically active and are of a healthy
weight and high cardiorespiratory fitness decrease the likelihood of
early mortality and cardiovascular morbidity. Nevertheless, it is clear
from the literature discussed that our understanding of the signifi-
cance and associations between pre-clinical markers of CVD and
obesity, physical activity and physical fitness in youth is poorly
understood. Findings are often contradictory which makes it difficult
to assert conclusively the best means of reversing potentially
unfavourable behaviours and cardiovascular and metabolic profiles.
Nonetheless, the relative importance of identifying specific risk fac-
tors in the prevention of CVD related disorders later in life requires
continued perseverance.   
Improved understanding of the effects of physical activity, physical
fitness and obesity upon CVD risk factors is vital. The school envi-
ronment, and in particular physical education, affords an ideal set-
ting to practice health-promoting behaviours and is widely recog-
nized as an important setting for intervention.59 Moreover, the
school setting provides a vehicle whereby interventions can reach a
large number of individuals from assorted socio-economic surround-
ings; avoid stigmatisation while affording an environment for youth
to partake in healthy behaviours. It is important therefore that
research continues to examine the best means of reversing poor
metabolic profiles in youth so that appropriate strategies can be
implemented that will the health and well-being of all individuals. 
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